These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28837826)

  • 1. Botulinum toxin in parkinsonism: The when, how, and which for botulinum toxin injections.
    Cardoso F
    Toxicon; 2018 Jun; 147():107-110. PubMed ID: 28837826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of botulinum toxin in Parkinson's disease.
    Jocson A; Lew M
    Parkinsonism Relat Disord; 2019 Feb; 59():57-64. PubMed ID: 30579818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
    Sheffield JK; Jankovic J
    Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in the management of parkinsonian disorders.
    Grippe T; Chen R
    Toxicon; 2023 Aug; 232():107209. PubMed ID: 37429465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
    J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin treatment in parkinsonism.
    Anandan C; Jankovic J
    J Neurol Sci; 2024 Jan; 456():122810. PubMed ID: 38056063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
    Bruno VA; Fox SH; Mancini D; Miyasaki JM
    Can J Neurol Sci; 2016 Sep; 43(5):697-702. PubMed ID: 27514242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy.
    Jongerius PH; van Hulst K; van den Hoogen FJ; Rotteveel JJ
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):351-3. PubMed ID: 16131993
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum Toxin for Axial Postural Abnormalities in Parkinson's Disease: A Systematic Review.
    Gandolfi M; Artusi CA; Imbalzano G; Camozzi S; Crestani M; Lopiano L; Tinazzi M; Geroin C
    Toxins (Basel); 2024 May; 16(5):. PubMed ID: 38787080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-oriented approach to botulinum toxin use.
    Jankovic J
    Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the use of botulinum toxin therapy in Parkinson's disease.
    Mills R; Bahroo L; Pagan F
    Curr Neurol Neurosci Rep; 2015 Jan; 15(1):511. PubMed ID: 25407133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in the management of sialorrhoea: a systematic review.
    Lim M; Mace A; Nouraei SA; Sandhu G
    Clin Otolaryngol; 2006 Aug; 31(4):267-72. PubMed ID: 16911641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials.
    Leonardi G; Alito A; Portaro S; Di Matteo B; Respizzi S; Kon E; Massazza G; Sconza C
    Eur J Pain; 2024 Mar; 28(3):369-381. PubMed ID: 37950343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin treatment for facial palsy: A systematic review.
    Cooper L; Lui M; Nduka C
    J Plast Reconstr Aesthet Surg; 2017 Jun; 70(6):833-841. PubMed ID: 28389084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin B reduces sialorrhea in parkinsonism.
    Racette BA; Good L; Sagitto S; Perlmutter JS
    Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of botulinum toxin type B for migraine and tension headaches.
    Fadeyi MO; Adams QM
    Am J Health Syst Pharm; 2002 Oct; 59(19):1860-2. PubMed ID: 12374073
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.
    Jost WH
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33503872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxin Injections in Musculoskeletal Disorders.
    Godoy IR; Donahue DM; Torriani M
    Semin Musculoskelet Radiol; 2016 Nov; 20(5):441-452. PubMed ID: 28002866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.